CO2023012574A2 - Nuevos derivados de tiazolopirimidinona - Google Patents
Nuevos derivados de tiazolopirimidinonaInfo
- Publication number
- CO2023012574A2 CO2023012574A2 CONC2023/0012574A CO2023012574A CO2023012574A2 CO 2023012574 A2 CO2023012574 A2 CO 2023012574A2 CO 2023012574 A CO2023012574 A CO 2023012574A CO 2023012574 A2 CO2023012574 A2 CO 2023012574A2
- Authority
- CO
- Colombia
- Prior art keywords
- new
- thiazolopyrimidinone
- derivatives
- thiazolopyrimidinone derivatives
- compound
- Prior art date
Links
- AKDQOJPOLRMVMF-UHFFFAOYSA-N [1,3]thiazolo[5,4-d]pyrimidine 3-oxide Chemical class N1=CN=C2S(=O)C=NC2=C1 AKDQOJPOLRMVMF-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a un compuesto de fórmula (I), en el que R1-R4 y A1-A3 son como se definen en la descripción y en las reivindicaciones. El compuesto de fórmula (I) se puede usar como un medicamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21163259 | 2021-03-17 | ||
| PCT/EP2022/056586 WO2022194801A1 (en) | 2021-03-17 | 2022-03-15 | New thiazolopyrimidinone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2023012574A2 true CO2023012574A2 (es) | 2023-09-29 |
Family
ID=74947249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2023/0012574A CO2023012574A2 (es) | 2021-03-17 | 2023-09-22 | Nuevos derivados de tiazolopirimidinona |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240018163A1 (es) |
| EP (1) | EP4308576A1 (es) |
| JP (1) | JP2024514421A (es) |
| KR (1) | KR20230157367A (es) |
| CN (1) | CN116981674A (es) |
| AU (1) | AU2022240935A1 (es) |
| BR (1) | BR112023018466A2 (es) |
| CA (1) | CA3212341A1 (es) |
| CL (1) | CL2023002705A1 (es) |
| CO (1) | CO2023012574A2 (es) |
| CR (1) | CR20230437A (es) |
| IL (1) | IL305203A (es) |
| MX (1) | MX2023010719A (es) |
| TW (1) | TW202302604A (es) |
| WO (1) | WO2022194801A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023064879A1 (en) * | 2021-10-13 | 2023-04-20 | Remix Therapeutics Inc. | Compounds and methods for modulating nucleic acid splicing |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2812004T3 (en) | 2012-02-10 | 2018-10-15 | Ptc Therapeutics Inc | COMPOUNDS FOR TREATMENT OF SPINAL MUSCLE DROPHY |
| AU2015261046C1 (en) | 2014-05-15 | 2019-07-25 | F. Hoffmann-La Roche Ag | Compounds for treating spinal muscular atrophy |
| AU2018282154B2 (en) * | 2017-06-05 | 2022-04-07 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| WO2019005980A1 (en) * | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| SG11202002610TA (en) | 2017-09-22 | 2020-04-29 | Hoffmann La Roche | Process for the prepration of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives |
| MX2020014315A (es) * | 2018-06-27 | 2021-05-27 | Ptc Therapeutics Inc | Compuestos de heteroarilo para tratar la enfermedad de huntington. |
| US11685746B2 (en) * | 2018-06-27 | 2023-06-27 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating Huntington's disease |
| BR112022020337A2 (pt) * | 2020-04-08 | 2022-12-13 | Remix Therapeutics Inc | Compostos e métodos para modulação de splicing |
-
2022
- 2022-03-15 EP EP22714821.0A patent/EP4308576A1/en active Pending
- 2022-03-15 CR CR20230437A patent/CR20230437A/es unknown
- 2022-03-15 MX MX2023010719A patent/MX2023010719A/es unknown
- 2022-03-15 BR BR112023018466A patent/BR112023018466A2/pt unknown
- 2022-03-15 WO PCT/EP2022/056586 patent/WO2022194801A1/en active Application Filing
- 2022-03-15 IL IL305203A patent/IL305203A/en unknown
- 2022-03-15 AU AU2022240935A patent/AU2022240935A1/en active Pending
- 2022-03-15 JP JP2023556976A patent/JP2024514421A/ja active Pending
- 2022-03-15 CN CN202280021604.7A patent/CN116981674A/zh active Pending
- 2022-03-15 KR KR1020237032218A patent/KR20230157367A/ko unknown
- 2022-03-15 CA CA3212341A patent/CA3212341A1/en active Pending
- 2022-03-16 TW TW111109552A patent/TW202302604A/zh unknown
-
2023
- 2023-09-11 CL CL2023002705A patent/CL2023002705A1/es unknown
- 2023-09-15 US US18/468,378 patent/US20240018163A1/en active Pending
- 2023-09-22 CO CONC2023/0012574A patent/CO2023012574A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022194801A1 (en) | 2022-09-22 |
| CR20230437A (es) | 2023-10-16 |
| BR112023018466A2 (pt) | 2023-10-10 |
| US20240018163A1 (en) | 2024-01-18 |
| CN116981674A (zh) | 2023-10-31 |
| TW202302604A (zh) | 2023-01-16 |
| IL305203A (en) | 2023-10-01 |
| AU2022240935A1 (en) | 2023-08-24 |
| MX2023010719A (es) | 2023-09-20 |
| JP2024514421A (ja) | 2024-04-02 |
| CA3212341A1 (en) | 2022-09-22 |
| CL2023002705A1 (es) | 2024-03-15 |
| KR20230157367A (ko) | 2023-11-16 |
| EP4308576A1 (en) | 2024-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019003178A2 (es) | Compuestos de dinucleótidos cíclicos | |
| CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
| CO2023012574A2 (es) | Nuevos derivados de tiazolopirimidinona | |
| CL2023000594A1 (es) | Compuestos heterocíclicos | |
| CR20160459A (es) | Nuevos derivados de piridina | |
| NI200600217A (es) | Derivados de imidazol utilizados como inhibidores de tafia | |
| CL2020003331A1 (es) | Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2 | |
| CL2023003154A1 (es) | Compuestos heterocíclicos | |
| CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| CO2018011231A2 (es) | Derivados de [1,2,3]triazolo[4,5-d]pirimidina con afinidad por los receptores canabinoides tipo-2 | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| CR20160448A (es) | Nuevos derivados de piridina | |
| BR112022012130A2 (pt) | Compostos antelmínticos compreendendo uma estrutura azaindólica | |
| PA8574701A1 (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen | |
| CL2018001493A1 (es) | Nuevos derivados de fenilo | |
| BR112022012126A2 (pt) | Compostos antelmínticos compreendendo uma estrutura quinolínica | |
| FR3092115B1 (fr) | analogues de GTP fluorescents et utilisation | |
| CL2022002255A1 (es) | Compuestos heterocíclicos de heteroarilo y usos de los mismos | |
| DOP2016000293A (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
| CO2018007756A2 (es) | Nuevos derivados pirrolidina | |
| CL2022001492A1 (es) | Nuevos inhibidores de braf como rompedores de la paradoja | |
| CL2020003248A1 (es) | Derivados de tetrahidrotienopiridina n-sustituidos y sus usos | |
| CO2023008475A2 (es) | Inhibidores de enzimas | |
| AR126383A1 (es) | Combinaciones insecticidas que comprenden un compuesto de antranilamida y tau-fluvalinato | |
| UY38423A (es) | Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen |